Table 3 Summary of development and performance outcomes reported for each article by sepsis-related endpoint
From: A scoping review on pediatric sepsis prediction technologies in healthcare
Sample Size | Participant age range | Sex (% male) | Setting | Time | Prevalence (%) | Validation | Features and ranking | Approach(es) | AUROC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sepsis | ||||||||||||
Ehwerhemuepha et al.69 | 537837 (visits) | Median: 4; IQR: 8 years | 53.60 | ED | 5–7 seconds from triage to predict | 0.20 | 50% training, 15% validation, 35% testing; 10-fold cross-validation | 47 (ranked) | Stochastic gradient boosting | 0.976 (0.972–0.981)a | 0.4414 (..) | 0.999 (..) |
Georgette et al.73 | 141510 (encounters) | Median: 4.5; IQR: (1.8–9.7) years | 51.70 | ED | 3.2 hours before IV vasoactive infusion | 3.40 | 66% training, 33% validation | 4 | Empirically derived shock index | 0.69–0.78 (0.65–0.80) | 0.835 (0.817–0.854) | 0.428 (0.424–0.433) |
Gilholm et al.46 | 3473 (patients) | Median: 2.1; IQR: (0.9–5.6) years | 55.00 | EDb | After clinical suspicion | 15.10 | 10-fold cross-validation | 16 (ranked) | Logistic regression (score) | 0.80 (0.78–0.82) | 0.90 (0.87–0.92) | 0.51 (0.49–0.53) |
Lamping et al.59 | 289 (patients) | Medians: 28–46; IQR: (4–120) months | 53.30–62.50 | ICU | After clinical suspicion | 19.38 | 3-fold cross-validation | 8 (ranked) | Random forest | 0.78 (0.70–0.87) | .. | .. |
Li et al.68 | 608 (patients) | 28.45 ± 21.47 months | 62.70–64.80 | ICU | During patient encounter | 50.80 | 70% training, 30% validation | 7 (ranked for KD) | Logistic regression (score) | 0.878 (..) | 0.94 (..) | 0.75 (..) |
Marassi et al.71 | 12749 (patients) | 0 to 18 years | .. | ICU | At onset | 2.11 | 80% training, 20% validation | 11 | XGBoost | .. | .. | .. |
Mawji et al.54 | 1612 (patients) | Medians: 13.1–16.5; IQR: (21.8–32.9) months | 51.50 | ED | At triage | 5.16 | 80% training, 20% validation; 10-fold cross-validation | 9 (ranked) | Logistic regression | 0.86 (..) | 0.59–0.91 (0.54–0.94) | 0.50–0.92 (0.45–0.94) |
Mercurio et al.62 | 35074 (encounters) | 97.7% between 0.11 and 18.0 years | 53.00 | ED | During patient encounter | 0.54 | 80% training, 20% validation; Cross-validation | 20 (ranked) | Random forest | 0.81 (..)a | 0.93 (..) | 0.84 (..) |
Classification and regression tree | 0.77 (..)a | 0.85 (..) | 0.70 (..) | |||||||||
Nguyen et al.58 | 3014 (admissions) | Median: 1.13; IQR: (0.15–4.30) years | 56.30 | ICU, Inpatient | Within the first 24, 48 hours with clinician suspicion | 4.40 | 10-fold cross-validation | 107 | Tree augmented naïve bayes | 0.866 (0.826–0.906), 0.867 (0.828–0.906) | 0.463 (0.376–0.550), 0.469 (0.377–0.550) | 0.949 (0.940–0.956), 0.953 (0.941–0.957) |
Sanchez-Pinto et al.43 | 218839 (encounters) | Medians: 2.6–3.7; IQR: (0.6–9.4) years | 47.00–51.50 | ED, ICU | During patient encounter | 1.20 (Mortality), 0.60–0.80 (Early mortality) | 10-fold cross-validation | 13 | Stacked regression models (score) | 0.71–0.92 (0.70–0.92), 0.79–0.96 (0.77–0.96)a | 0.23–0.81 (0.20–0.85), 0.31–0.90 (0.26–0.93) | 0.53–0.99 (0.52–1.00), 0.52–0.99 (0.52–0.99) |
Schlapbach et al.56 | 4403 (patients) | Median: 2.1; IQR: (0.62–6.68) years | 55.50 | ICU | Within 1 hour of admission | 5.20 (30-day mortality) | .. | 6 (ranked) | Logistic regression (score) | 0.810–0.817 (0.779–0.855) | .. | .. |
Sepanski et al.51 | 35586 (encounters) | Mean: 5.7; SD: 5.4 years | .. | EDb | Within 24–48 hours | 0.20 | Split-sample validation | 12 | Logistic regression | 0.849–0.918 (0.782–0.985) | 0.703–0.770 (0.599–0.866) | 0.977–0.981 (0.976–0.982) |
Solé‐Ribalta et al.65 | 210 (patients) | Median: 42.7; IQR: (5.7–138.6) months | 52.40 | ED, Inpatient | After clinical suspicion | 69.52 | k-fold cross-validation | 11 (ranked) | Logistic regression (score) | 0.886 (0.845–0.927) | 0.98 (..) | 0.767 (..) |
Solé‐Ribalta et al.66 | 266 (patients) | Median: 37.2; IQR: (4.2–127.8) months | 53.80 | ED | After clinical suspicion | 64.66 | k-fold cross-validation | 4 (ranked) | Logistic regression (score) | 0.825 (0.772–0.878) | 0.88–0.90 (..) | 0.45–0.62 (..) |
Spaeder et al.60 | 1521 (patients) | Medians: 1.4–3.2; IQR: (0.3–7.4) years | 50.3–53.7 | ICU | Within 24 hours | 10.20 (of admissions) | Cross-validation | 37 (ranked) | Random forest | 0.762 (0.728–0.789) | 0.102 (..) | 0.16 (..) |
9 (ranked) | Logistic regression | 0.735 (0.710–0.771) | 0.215 (..) | 0.204 (..) | ||||||||
Stephen et al.61 | 1425 (patients) | 79.8–84.2% between 1 and > 18 years | 53.70 | ICUb | Within 24 hours, Anytime | 1.40 (of encounters) | 84.6% training, 15.4% validation; 40-fold cross-validation | 13 (ranked) | Logistic regression (score) | ..a | 0.49 (0.37–0.61), 0.72 (0.60–0.81) | 0.98 (0.98–0.98), 0.96 (0.96–0.96) |
Yang et al.64 | 65 (patients) | Between 8.8–9.3 ± 4.6–4.9 years | 42.9–56.7 | ICU | After clinical suspicion | 53.80 | 10-fold cross-validation | 4 | Logistic regression (score) | 0.826–0.917 (..) | .. | .. |
Ying et al.72 | 667 (patients) | 0 to 10 years | .. | ICU | After clinical suspicion | 74.50 | 67% training, 33% validation; 10-fold cross-validation | 18 | Gradient boosting machine | 0.943 (0.900–0.978)a | 0.941 (..) | 0.787 (..) |
Severe Sepsis | ||||||||||||
Ehwerhemuepha et al.69 | 537837 (visits) | Median: 4; IQR: (8) years | 53.60 | ED | 5–7 seconds from triage to predict | 0.05 | 50% training, 15% validation, 35% testing; 10-fold cross-validation | 47 (ranked) | Stochastic gradient boosting | 0.99 (0.985–0.995)a | 0.845 (..) | 0.99 (..) |
Kamaleswaran et al.55 | 493 (patients) | 6 to 18 years | .. | ICU | 2, 8 hours earlier than existing alert | 4.06 | 5-fold cross-validation | 3 (ranked), 6 (ranked) | Logistic regression | 0.77 (0.63–0.91), 0.56 (0.39–0.76) | 0.55 (..), 0.393 (..) | 0.874 (..), 0.771 (..) |
14 (ranked) | Random forest | .. | 0.80 (..), 0.611 (..) | 0.796 (..), 0.823 (..) | ||||||||
30 | Convolutional neural network | .. | 0.75 (..), 0.76 (..) | 0.83 (..), 0.81 (..) | ||||||||
Le et al.52 | 9486 (patients) | Median: 10; IQR: (5–14) years | 50.39 | Inpatient | 4 hours before onset, at onset | 1.06 | 4-fold cross-validation | 7 (ranked), 6 (ranked) | Boosted ensembles of decision trees | 0.718 (..), 0.916 (..) | 0.75 (..), 0.75 (..) | 0.70 (..), 0.94 (..) |
Mercurio et al.62 | 35074 (encounters) | 97.7% between 0.11 and 18.0 years | 53.00 | ED | During patient encounter | 0.54 | 80% training, 20% validation; Cross-validation | 20 (ranked) | Random forest | 0.81 (..)a | 0.93 (..) | 0.84 (..) |
Classification and regression tree | 0.77 (..)a | 0.85 (..) | 0.70 (..) | |||||||||
Sepanski et al.51 | 35586 (encounters) | Mean: 5.7; SD: 5.4 years | .. | EDb | Within 24–48 hours | 0.20 | Split-sample validation | 12 | Logistic regression | 0.849–0.918 (0.782–0.985) | 0.703–0.770 (0.599–0.866) | 0.977–0.981 (0.976–0.982) |
Septic Shock | ||||||||||||
Aviles-Robles et al.63 | 404 (febrile neutropenia episodes) | Median: 7.7; IQR (4.4–11.7) years | 48.80 | ED | During patient encounter | 16.1 (of febrile neutropenia episodes) | 80% training, 20% validation | 9 (ranked) | Logistic regression | 0.66 (0.56–0.76) | 0.96 (..) | 0.33 (..) |
Georgette et al.73 | 141510 (encounters) | Median: 4.5; IQR: (1.8–9.7) years | 51.70 | ED | 3.2 hours before IV vasoactive infusion | 0.36 | 66% training, 33% validation | 4 | Empirically derived shock index | 0.82–0.95 (0.65–0.97) | 0.813 (0.752–0.874) | 0.835 (0.832–0.838) |
Liu et al.70 | 6161 (patients) | Mean: 6.04; SD: 5.75 years | 55.70 | ICU | Median early warning: 8.9 hours | 17.58 | 70% training, 30% validation | 26 (top 10 ranked) | XGBoost | 0.90 (..) | 0.84 (..) | 0.82 (..) |
Median early warning: 12.0 hours | 26 (top 10 ranked) | Generalized linear model | 0.87 (..) | 0.83 (..) | 0.75 (..) | |||||||
Mercurio et al.62 | 35074 (encounters) | 97.7% between 0.11 and 18.0 years | 53.00 | ED | During patient encounter | 0.54 | 80% training, 20% validation; Cross-validation | 20 (ranked) | Random forest | 0.81 (..)a | 0.93 (..) | 0.84 (..) |
Classification and regression tree | 0.77 (..)a | 0.85 (..) | 0.70 (..) | |||||||||
Sanchez-Pinto et al.43 | 218839 (encounters) | Medians: 2.6–3.7; IQR: (0.6–9.4) years | 47.00–51.50 | ED, ICU | During patient encounter | 1.20 (Mortality), 0.60–0.80 (Early mortality) | 10-fold cross-validation | 13 | Stacked regression models (score) | 0.71–0.92 (0.70–0.92), 0.79–0.96 (0.77–0.96)a | 0.23–0.81 (0.20–0.85), 0.31–0.90 (0.26–0.93) | 0.53–0.99 (0.52–1.00), 0.52–0.99 (0.52–0.99) |
Schlapbach et al.56 | 4403 (patients) | Median: 2.1; IQR: (0.62–6.68) years | 55.50 | ICU | Within 1 hour of admission | 5.20 (30-day mortality) | .. | 6 (ranked) | Logistic regression (score) | 0.810–0.817 (0.779–0.855) | .. | .. |
Scott et al.44 | 2464 (visits) | Medians: 5.6–6.0; IQR: (2.1–13.4) years | 49.00–55.00 | ED | At hospital arrival: temporal, geographic | 11.40 | 10-fold cross validation, temporal and geographic validation | 9 (ranked) | Elastic net regularization | 0.75 (0.69–0.81), 0.87 (0.73–1.00) | 0.82 (0.72–0.90), 0.90 (0.55–1.00) | 0.48 (0.44–0.52), 0.32 (0.21–0.46) |
Scott et al.45 | 2318 (visits) | Medians: 4.9–5.9; IQR: (10) years | 52.00–55.00 | ED, ICU | Within 2 hours of hospital arrival: temporal, geographic | 8.50 | Temporal and geographic validation | 20 (ranked) | Logistic regression | 0.83 (0.78–0.89), 0.83 (0.60–1.00) | 0.84 (0.71–0.92), 0.80 (0.28–0.99) | 0.65 (0.61–0.69), 0.40 (0.27–0.54) |
Xiang et al.57 | 1238 (patients) | Median: 58.3; IQR: (25.8–111.0) months | 59.60 | Inpatient | 4, 8, 12, 24 hours before onset | 2.84 (of observation periods) | 78% training, 22% validation | 23 (ranked) | XGBoost | 0.925 (..), 0.925 (..), 0.900 (..), 0.930 (..) | .. | .. |
Ying et al.72 | 667 (patients) | 0 to 10 years | .. | ICU | After clinical suspicion | 74.50 | 67% training, 33% validation; 10-fold cross-validation | 18 | Gradient boosting machine | 0.943 (0.900–0.978)a | 0.941 (..) | 0.787 (..) |